This book provides a comprehensive overview of the multidisciplinary management of meningiomas, followed by evaluation and management considerations along a spectrum of benign to more malignant behavior. It outlines the management of presumed Grade 1 tumors and how to identify features of tumors radiographically and clinically that may support a benign course rather than aggressive and vice versa. Following a stepwise progression from simple to complex, chapters introduce and tackle more aggressive meningiomas and tumor recurrence (of all Grades), with paradigms for evaluation and treatment.…mehr
This book provides a comprehensive overview of the multidisciplinary management of meningiomas, followed by evaluation and management considerations along a spectrum of benign to more malignant behavior. It outlines the management of presumed Grade 1 tumors and how to identify features of tumors radiographically and clinically that may support a benign course rather than aggressive and vice versa. Following a stepwise progression from simple to complex, chapters introduce and tackle more aggressive meningiomas and tumor recurrence (of all Grades), with paradigms for evaluation and treatment. Tumor biology and genomics are fundamental and largely focused in the book. More recent findings which have directed personalized medicine and clinical trials are also addressed. Meningiomas: Comprehensive Strategies for Management addresses all aspects of the evaluation and care of patients with all WHO grades of meningiomas. It is highly informative and provides clarity for a wide audience of neurosurgeons, reconstructive surgeons, oncologists, neurologists, radiation oncologists, pathologists, radiologists, residents and students who treat these patients and those who are training for a career in managing patients with these potentially challenging tumors. Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Die Herstellerinformationen sind derzeit nicht verfügbar.
Autorenporträt
Jennifer Moliterno Chief of Neurosurgical Oncology, Yale New Haven Hospital and Smilow Cancer Hospital Co-Director, Yale Brain Tumor Center at Smilow Cancer Hospital Associate Professor, Department of Neurosurgery, Yale School of Medicine, Yale University Department of Neurosurgical Oncology Yale School of Medicine New Haven, CT USA Antonio Omuro Chief of Neuro-Oncology, Yale New Haven Hospital and Smilow Cancer Hospital Director, Yale Brain Tumor Center at Smilow Cancer Hospital Professor, Department of Neurology Yale School of Medicine, Yale University New Haven, CT USA
Inhaltsangabe
Meningiomas: Overview.- Histopathology and Grading of Meningiomas.- Radiology.- The Genomic Landscape of Meningiomas.- The Initial Evaluation and Surveillance of Meningiomas.- Surgical Considerations for Newly Diagnosed Meningiomas.- Endoscopic and Minimally Invasive Meningioma Surgery.- Spinal Meningioma: Comprehensive Strategies for Management.- Radiation Therapy for the Management of Benign Meningioma.- Benign Tumor Recurrence and Management of More Aggressive Meningiomas.- Surgical Considerations for Recurrent Meningiomas.- Radiotherapy for Aggressive Meningiomas and Recurrent WHO Grade I Meningiomas.- The Role of Medical Therapy.- Emerging Therapies I: Precision Medicine, Targeted Therapies, and Mutation-Specific Approaches.- Emerging Therapies II: Immunotherapies, Novel Radiotherapy Techniques and Other Experimental Approaches.
Meningiomas: Overview.- Histopathology and Grading of Meningiomas.- Radiology.- The Genomic Landscape of Meningiomas.- The Initial Evaluation and Surveillance of Meningiomas.- Surgical Considerations for Newly Diagnosed Meningiomas.- Endoscopic and Minimally Invasive Meningioma Surgery.- Spinal Meningioma: Comprehensive Strategies for Management.- Radiation Therapy for the Management of Benign Meningioma.- Benign Tumor Recurrence and Management of More Aggressive Meningiomas.- Surgical Considerations for Recurrent Meningiomas.- Radiotherapy for Aggressive Meningiomas and Recurrent WHO Grade I Meningiomas.- The Role of Medical Therapy.- Emerging Therapies I: Precision Medicine, Targeted Therapies, and Mutation-Specific Approaches.- Emerging Therapies II: Immunotherapies, Novel Radiotherapy Techniques and Other Experimental Approaches.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826